49 results
Search Results
2. Pharmacokinetics of spironolactone in man
3. Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man
4. Biochemistry and pharmacology of the crotoxin complex: II. Possible interrelationships between toxicity and organ distribution of phospholipase A, crotapotin and their combination
5. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats
6. Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability
7. Absorption and distribution of etoricoxib in plasma, CSF, and wound tissue in patients following hip surgery—a pilot study
8. Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers
9. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans
10. Pharmacological profile and toxicity of fluorescein-labelled sinistrin, a novel marker for GFR measurements
11. Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants
12. Ocular pharmacokinetics of verapamil in rabbits
13. Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effects
14. Pharmacokinetic and α1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport
15. Theophylline kinetics in peripheral tissues in vivo in humans
16. The effect of carbidopa on the pharmacokinetics and metabolism of intravenously administered levodopa in blood plasma and skeletal muscle
17. Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli
18. In vivo pharmacokinetics of levodopa and 3-O-methyldopa in muscle: A microdialysis study
19. Effect of cigarette smoke on pharmacokinetics of oral, intrarectal, or intravenous indomethacin in rats
20. Pharmacokinetic properties of the antimuscarinic drug [3H]-hexahydro-sila-difenidol in the rat
21. Local tetanus in cats: Neuropharmacokinetics of 125I-tetanus toxin
22. Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis
23. Vagal ascent and distribution of 125I-tetanus toxin after injection into the anterior wall of the stomach
24. The pharmacokinetics and metabolism of Kö 592 in man, dog and rat
25. Influence of 22-day treatment on the anticonvulsant properties of cannabinoids
26. Chronopharmacokinetics of ethanol: II. Circadian rhythm in rate of blood level decline in a single subject
27. Local tetanus in cats: The influence of neuromuscular activity on spinal distribution of 125I labelled tetanus toxin
28. The pharmacokinetics and organ distribution of ajmaline and quinidine in the mouse
29. 125I-Labelled botulinum a neurotoxin: Pharmacokinetics in cats after intramuscular injection
30. A gas chromatographic method for determining haloperidol: A sensitive procedure for studying serum concentration and pharmacokinetics of haloperidol in patients
31. Pharmacodynamics, pharmacokinetics and metabolism of digitoxin and derivatives in cats
32. Kinetics and metabolism of 2,2-diethylallylacetamide in dog and man
33. Distribution of 125I-tetanus toxin and 125I-toxoid in rats with generalized tetanus, as influenced by antitoxin
34. Possible site of the in vivo disposition of sodium nitroprusside in the rat
35. Pharmacokinetics of tetrahydronorharmane (tetrahydro-β-carboline) in rats
36. Thallium pharmacokinetics and its modification by Prussian Blue
37. Pharmacokinetics in the rat of the hallucinogenic alkaloids harmine and harmaline
38. Supporting evidence for a role of neural ascent of toxin in the pathogenesis of general tetanus in cats
39. Metabolic fate of 125I-tetanus toxin in the spinal cord of rats and cats with early local tetanus
40. Kinetics and metabolism of amphetamine in the brain of rats of different ages
41. Propranolol in conscious spontaneously hypertensive rats: II. Disposition after subcutaneous and intracerebroventricular administration
42. Factors responsible for reduced pharmacological activity in rats of pentetrazol administered orally
43. Effect of nafenopin (SU-13,437) on liver function: Mechanism of choleretic effect
44. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain
45. Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse
46. Bronchoconstrictor and hypotensive effects in relation to pharmacokinetics of tachykinins in the guinea-pig —evidence for extraneuronal cleavage of neuropeptide K to neurokinin A
47. β-Methyl-digoxin: IV. Blood levels, tissue distribution and metabolism in the guinea-pig
48. Evaluation of the enterohepatic circulation after 3H-digoxin administration in the rat
49. Effect of age on levels of diazepam in plasma and brain of rats
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.